La vendita allo scoperto per Equifax dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di Equifax. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

Equifax (NYSE:EFX) Azioni, Report sulle vendite allo scoperto

Equifax

Along with Experian and TransUnion, Equifax is one of the leading credit bureaus in the United States. Equifax's credit reports provide credit histories on millions of consumers, and the firm's services are critical to lenders' credit decisions. In addition, over 40% of the firm's revenue comes from workforce solutions, which provides income verification and employer human resources services. Equifax generates just over 20% of its revenue from outside the United States.

Equifax Inc

Effect Network

Enerflex Ltd

News

GOOG

Equifax Expanded Its Partnership With Google Cloud To Securely Deliver Anonymized, Differentiated Data Assets On The Google Cloud Analytics Hub, Google Cloud's Unified Data Platform

Equifax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>) has outperformed the market over the past 20 years by 4.23% on an annualized basis producing an average annual return of 12.75%. Currently, Equifax has a market capitalization of $34.91 billion. 
Buying $100 In EFX: If an investor had bought $100 of EFX stock 20 years ago, it would be worth $1,098.68 today based on a price of $282.17 for EFX at the time of writing.
<h3>Equifax's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1728408614_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

$100 Invested In This Stock 20 Years Ago Would Be Worth $1,100 Today

Oppenheimer analyst Owen Lau maintains Equifax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>) with a Outperform and raises the price target from $300 to $315.

Price Target

Analyst Ratings

Oppenheimer Maintains Outperform on Equifax, Raises Price Target to $315

Equifax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>) underwent analysis by 15 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">5</td>
<td style="text-align: right;">7</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $312.67, a high estimate of $380.00, and a low estimate of $271.00. This upward trend is evident, with the current average reflecting a 13.49% increase from the previous average price target of $275.50.
<img src="https://www.benzinga.com/files/images/story/2024/1727884868_0.png" alt="price target chart" />
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
The perception of Equifax by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Jason Haas</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$375.00</td>
<td>$340.00</td>
</tr>
<tr>
<td>Kevin Mcveigh</td>
<td>UBS</td>
<td>Announces</td>
<td>Buy</td>
<td>$360.00</td>
<td>-</td>
</tr>
<tr>
<td>Manav Patnaik</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$380.00</td>
<td>$300.00</td>
</tr>
<tr>
<td>Toni Kaplan</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$271.00</td>
<td>$250.00</td>
</tr>
<tr>
<td>George Tong</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Neutral</td>
<td>$307.00</td>
<td>$277.00</td>
</tr>
<tr>
<td>Jason Haas</td>
<td>Wells Fargo</td>
<td>Announces</td>
<td>Overweight</td>
<td>$340.00</td>
<td>-</td>
</tr>
<tr>
<td>Arthur Truslove</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$304.00</td>
<td>$263.00</td>
</tr>
<tr>
<td>Andrew Steinerman</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$300.00</td>
<td>$273.00</td>
</tr>
<tr>
<td>Shlomo Rosenbaum</td>
<td>Stifel</td>
<td>Raises</td>
<td>Buy</td>
<td>$305.00</td>
<td>$265.00</td>
</tr>
<tr>
<td>Owen Lau</td>
<td>Oppenheimer</td>
<td>Raises</td>
<td>Outperform</td>
<td>$300.00</td>
<td>$272.00</td>
</tr>
<tr>
<td>George Tong</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Neutral</td>
<td>$277.00</td>
<td>$246.00</td>
</tr>
<tr>
<td>Jeffrey Meuler</td>
<td>Baird</td>
<td>Raises</td>
<td>Outperform</td>
<td>$290.00</td>
<td>$260.00</td>
</tr>
<tr>
<td>Kyle Peterson</td>
<td>Needham</td>
<td>Raises</td>
<td>Buy</td>
<td>$320.00</td>
<td>$305.00</td>
</tr>
<tr>
<td>Heather Balsky</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$286.00</td>
<td>$255.00</td>
</tr>
<tr>
<td>Scott Wurtzel</td>
<td>Wolfe Research</td>
<td>Announces</td>
<td>Outperform</td>
<td>$275.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Equifax. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Equifax compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of Equifax's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Equifax's market standing. Stay informed and make data-driven decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/EFX/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Equifax analyst ratings.</a>
<h2>Get to Know Equifax Better</h2>
Along with Experian and TransUnion, Equifax is one of the leading credit bureaus in the United States. Equifax's credit reports provide credit histories on millions of consumers, and the firm's services are critical to lenders' credit decisions. In addition, over 40% of the firm's revenue comes from workforce solutions, which provides income verification and employer human resources services. Equifax generates just over 20% of its revenue from outside the United States.
<h3>Equifax's Financial Performance</h3>
Market Capitalization: Surpassing industry standards, the company's market capitalization asserts its dominance in terms of size, suggesting a robust market position.
Revenue Growth: Equifax's remarkable performance in 3 months is evident. As of 30 June, 2024, the company achieved an impressive revenue growth rate of 8.57%. This signifies a substantial increase in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Industrials sector.
Net Margin: Equifax's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 11.46% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): Equifax's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of 3.54%, the company may face hurdles in achieving optimal financial returns.
Return on Assets (ROA): Equifax's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of 1.34%, the company may face hurdles in achieving optimal financial performance.
Debt Management: The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of 1.17, caution is advised due to increased financial risk.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Critical Insights From Equifax Analyst Ratings: What You Need To Know

Wells Fargo analyst Jason Haas maintains Equifax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>) with a Overweight and raises the price target from $340 to $375.

Wells Fargo Maintains Overweight on Equifax, Raises Price Target to $375

UBS analyst Kevin Mcveigh initiates coverage on Equifax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>) with a Buy rating and announces Price Target of $360.

Initiation

UBS Initiates Coverage On Equifax with Buy Rating, Announces Price Target of $360

In the current market session, Equifax Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>) share price is at $291.91, after a 0.44% spike. Moreover, over the past month, the stock decreased by 4.93%, but in the past year, went up by 62.98%. Shareholders might be interested in knowing whether the stock is overvalued, even if the company is performing up to par in the current session. 

<img src="https://www.benzinga.com/files/images/story/2024/1727449255_0.png" alt="Past Year Chart" />

<h3>Equifax P/E Compared to Competitors</h3>
The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and aggregate market data for the industry or the indices, such as S&amp;P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also could indicate that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future. 
Compared to the aggregate P/E ratio of 50.78 in the Professional Services industry, Equifax Inc. has a higher P/E ratio of 62.1. Shareholders might be inclined to think that Equifax Inc. might perform better than its industry group. It's also possible that the stock is overvalued. 

<img src="https://www.benzinga.com/files/images/story/2024/1727449255_1.png" alt="Guage" />

In summary, while the price-to-earnings ratio is a valuable tool for investors to evaluate a company's market performance, it should be used with caution. A low P/E ratio can be an indication of undervaluation, but it can also suggest weak growth prospects or financial instability. Moreover, the P/E ratio is just one of many metrics that investors should consider when making investment decisions, and it should be evaluated alongside other financial ratios, industry trends, and qualitative factors. By taking a comprehensive approach to analyzing a company's financial health, investors can make well-informed decisions that are more likely to lead to successful outcomes.

Intraday Update

Markets

P/E Ratio Insights for Equifax

Equifax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>) has outperformed the market over the past 20 years by 4.48% on an annualized basis producing an average annual return of 12.97%. Currently, Equifax has a market capitalization of $37.39 billion. 
Buying $1000 In EFX: If an investor had bought $1000 of EFX stock 20 years ago, it would be worth $11,290.99 today based on a price of $302.19 for EFX at the time of writing.
<h3>Equifax's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1726857087_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$1000 Invested In This Stock 20 Years Ago Would Be Worth $11,000 Today

Equifax Launched A New Merchant Data Network, An Equifax Cloud-based Data Network To Help Provide Greater Visibility Into The Financial Profiles Of US Small Businesses

Barclays analyst Manav Patnaik maintains Equifax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>) with a Overweight and raises the price target from $300 to $380.

Barclays Maintains Overweight on Equifax, Raises Price Target to $380

Across the recent three months, 12 analysts have shared their insights on Equifax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>), expressing a variety of opinions spanning from bullish to bearish.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">5</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for Equifax, revealing an average target of $297.92, a high estimate of $340.00, and a low estimate of $271.00. This upward trend is apparent, with the current average reflecting a 11.75% increase from the previous average price target of $266.60.
<img src="https://www.benzinga.com/files/images/story/2024/1726142483_0.png" alt="price target chart" />
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
The standing of Equifax among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Toni Kaplan</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$271.00</td>
<td>$250.00</td>
</tr>
<tr>
<td>George Tong</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Neutral</td>
<td>$307.00</td>
<td>$277.00</td>
</tr>
<tr>
<td>Jason Haas</td>
<td>Wells Fargo</td>
<td>Announces</td>
<td>Overweight</td>
<td>$340.00</td>
<td>-</td>
</tr>
<tr>
<td>Arthur Truslove</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$304.00</td>
<td>$263.00</td>
</tr>
<tr>
<td>Andrew Steinerman</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$300.00</td>
<td>$273.00</td>
</tr>
<tr>
<td>Shlomo Rosenbaum</td>
<td>Stifel</td>
<td>Raises</td>
<td>Buy</td>
<td>$305.00</td>
<td>$265.00</td>
</tr>
<tr>
<td>Owen Lau</td>
<td>Oppenheimer</td>
<td>Raises</td>
<td>Outperform</td>
<td>$300.00</td>
<td>$272.00</td>
</tr>
<tr>
<td>George Tong</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Neutral</td>
<td>$277.00</td>
<td>$246.00</td>
</tr>
<tr>
<td>Jeffrey Meuler</td>
<td>Baird</td>
<td>Raises</td>
<td>Outperform</td>
<td>$290.00</td>
<td>$260.00</td>
</tr>
<tr>
<td>Kyle Peterson</td>
<td>Needham</td>
<td>Raises</td>
<td>Buy</td>
<td>$320.00</td>
<td>$305.00</td>
</tr>
<tr>
<td>Heather Balsky</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$286.00</td>
<td>$255.00</td>
</tr>
<tr>
<td>Scott Wurtzel</td>
<td>Wolfe Research</td>
<td>Announces</td>
<td>Outperform</td>
<td>$275.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Equifax. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Equifax compared to the broader market.</li>
<li>Price Targets: Analysts predict movements in price targets, offering estimates for Equifax's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Equifax's market standing. Stay informed and make data-driven decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/EFX/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Equifax analyst ratings.</a>
<h2>All You Need to Know About Equifax</h2>
Along with Experian and TransUnion, Equifax is one of the leading credit bureaus in the United States. Equifax's credit reports provide credit histories on millions of consumers, and the firm's services are critical to lenders' credit decisions. In addition, over 40% of the firm's revenue comes from workforce solutions, which provides income verification and employer human resources services. Equifax generates just over 20% of its revenue from outside the United States.
<h3>Unraveling the Financial Story of Equifax</h3>
Market Capitalization Analysis: Above industry benchmarks, the company's market capitalization emphasizes a noteworthy size, indicative of a strong market presence.
Revenue Growth: Equifax displayed positive results in 3 months. As of 30 June, 2024, the company achieved a solid revenue growth rate of approximately 8.57%. This indicates a notable increase in the company's top-line earnings. When compared to others in the Industrials sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Equifax's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 11.46% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of 3.54%, the company may need to address challenges in generating satisfactory returns for shareholders.
Return on Assets (ROA): Equifax's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of 1.34%, the company may face hurdles in achieving optimal financial returns.
Debt Management: Equifax's debt-to-equity ratio is notably higher than the industry average. With a ratio of 1.17, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.
<h2>The Significance of Analyst Ratings Explained</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Beyond The Numbers: 12 Analysts Discuss Equifax Stock

Morgan Stanley analyst Toni Kaplan maintains Equifax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>) with a Equal-Weight and raises the price target from $250 to $271.

Morgan Stanley Maintains Equal-Weight on Equifax, Raises Price Target to $271

Equifax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>) has outperformed the market over the past 10 years by 3.84% on an annualized basis producing an average annual return of 14.31%. Currently, Equifax has a market capitalization of $36.14 billion. 
Buying $100 In EFX: If an investor had bought $100 of EFX stock 10 years ago, it would be worth $380.13 today based on a price of $292.08 for EFX at the time of writing.
<h3>Equifax's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1725895815_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

If You Invested $100 In This Stock 10 Years Ago, You Would Have $400 Today

Workday's Employment Verification Connector For Equifax Will Help Workday Customers Verify Employment and Income Details Faster and More Efficiently, Streamlining Operations and Reducing Costs
PLEASANTON, Calif. and ATLANTA, Aug. 22, 2024 /PRNewswire/ --&nbsp;<a href="https://www.workday.com/">Workday, Inc.</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WDAY#NASDAQ">WDAY</a>), a leading provider of solutions to help organizations manage their <a href="https://www.workday.com/en-us/products/human-capital-management/overview.html">people</a> and <a href="https://www.workday.com/en-us/products/financial-management/overview.html">money</a>, and <a href="https://www.equifax.com/">Equifax</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>), a global data, analytics and technology company, today announced a new strategic partnership to help make employment and income verifications for Workday customers' employees easier and faster than ever before.

WDAY

Workday And Equifax Announce Strategic Partnership To Help Make Employment And Income Verifications For Workday Customers' Employees Easier

In the latest quarter, 11 analysts provided ratings for Equifax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>), showcasing a mix of bullish and bearish perspectives.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">5</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $300.36, along with a high estimate of $340.00 and a low estimate of $275.00. This upward trend is apparent, with the current average reflecting a 11.89% increase from the previous average price target of $268.44.
<img src="https://www.benzinga.com/files/images/story/2024/1724176904_0.png" alt="price target chart" />
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive Equifax. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>George Tong</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Neutral</td>
<td>$307.00</td>
<td>$277.00</td>
</tr>
<tr>
<td>Jason Haas</td>
<td>Wells Fargo</td>
<td>Announces</td>
<td>Overweight</td>
<td>$340.00</td>
<td>-</td>
</tr>
<tr>
<td>Arthur Truslove</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$304.00</td>
<td>$263.00</td>
</tr>
<tr>
<td>Andrew Steinerman</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$300.00</td>
<td>$273.00</td>
</tr>
<tr>
<td>Shlomo Rosenbaum</td>
<td>Stifel</td>
<td>Raises</td>
<td>Buy</td>
<td>$305.00</td>
<td>$265.00</td>
</tr>
<tr>
<td>Owen Lau</td>
<td>Oppenheimer</td>
<td>Raises</td>
<td>Outperform</td>
<td>$300.00</td>
<td>$272.00</td>
</tr>
<tr>
<td>George Tong</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Neutral</td>
<td>$277.00</td>
<td>$246.00</td>
</tr>
<tr>
<td>Jeffrey Meuler</td>
<td>Baird</td>
<td>Raises</td>
<td>Outperform</td>
<td>$290.00</td>
<td>$260.00</td>
</tr>
<tr>
<td>Kyle Peterson</td>
<td>Needham</td>
<td>Raises</td>
<td>Buy</td>
<td>$320.00</td>
<td>$305.00</td>
</tr>
<tr>
<td>Heather Balsky</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$286.00</td>
<td>$255.00</td>
</tr>
<tr>
<td>Scott Wurtzel</td>
<td>Wolfe Research</td>
<td>Announces</td>
<td>Outperform</td>
<td>$275.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Equifax. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Equifax compared to the broader market.</li>
<li>Price Targets: Analysts provide insights into price targets, offering estimates for the future value of Equifax's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Equifax's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/EFX/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Equifax analyst ratings.</a>
<h2>Delving into Equifax's Background</h2>
Along with Experian and TransUnion, Equifax is one of the leading credit bureaus in the United States. Equifax's credit reports provide credit histories on millions of consumers, and the firm's services are critical to lenders' credit decisions. In addition, over 40% of the firm's revenue comes from workforce solutions, which provides income verification and employer human resources services. Equifax generates just over 20% of its revenue from outside the United States.
<h3>Breaking Down Equifax's Financial Performance</h3>
Market Capitalization Analysis: The company's market capitalization is above the industry average, indicating that it is relatively larger in size compared to peers. This may suggest a higher level of investor confidence and market recognition.
Revenue Growth: Equifax displayed positive results in 3 months. As of 30 June, 2024, the company achieved a solid revenue growth rate of approximately 8.57%. This indicates a notable increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Industrials sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 11.46%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): Equifax's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of 3.54%, the company may face hurdles in achieving optimal financial performance.
Return on Assets (ROA): Equifax's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of 1.34%, the company may face hurdles in achieving optimal financial returns.
Debt Management: Equifax's debt-to-equity ratio is notably higher than the industry average. With a ratio of 1.17, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Forecasting The Future: 11 Analyst Projections For Equifax

Goldman Sachs analyst George Tong maintains Equifax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>) with a Neutral and raises the price target from $277 to $307.

Goldman Sachs Maintains Neutral on Equifax, Raises Price Target to $307

Equifax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>) has outperformed the market over the past 10 years by 3.42% on an annualized basis producing an average annual return of 14.16%. Currently, Equifax has a market capitalization of $36.16 billion. 
Buying $100 In EFX: If an investor had bought $100 of EFX stock 10 years ago, it would be worth $374.57 today based on a price of $292.27 for EFX at the time of writing.
<h3>Equifax's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1724077810_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$100 Invested In Equifax 10 Years Ago Would Be Worth This Much Today

A month has gone by since the last earnings report for Equifax (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/efx#NYSE">EFX</a>). Shares have added about 11.1% in that time frame, outperforming the S&amp;P 500.
Will the recent positive trend continue leading up to its next earnings release, or is Equifax due for a pullback? Before we dive into how investors and analysts have reacted as of late, let&#39;s take a quick look at its most recent earnings report in order to get a better handle on the important catalysts.
<h3>Equifax Beats on Q2 Earnings&nbsp;</h3>
Equifax reported impressive second-quarter 2024 results, wherein earnings and revenues surpassed the Zacks Consensus Estimate.
EFX&#39;s adjusted earnings (excluding 51 cents from non-recurring items) were $1.82 per share, outpacing the Zacks Consensus Estimate by 5.8% and increasing by 6.4% on a year-over-year basis. Total revenues of $1.4 billion surpassed the consensus estimate by a slight margin and jumped 8.6% from the year-ago quarter.
<h3>Segmental Information</h3>
Revenues in the Workforce Solutions segment totaled $612.9 million, increasing 5% from the year-ago quarter and beating our expectation of $600.2 million. Within the segment, Verification Services&#39; revenues of $515.9 million were up 9% year over year. Employer Services&#39; revenues of $97 million declined 11% on a year-over-year basis.
USIS segment&#39;s revenues were $478.3 million, grew 7% from the year-ago quarter and missing our anticipation of $481.9 million. Within the segment, Online Information Solutions&#39; revenues of $377.8 million increased 5% year over year. Mortgage Solutions&#39; revenues of $40.4 million jumped 33% from the year-ago quarter. Financial Marketing Services&#39; revenues were $60.1 million, which increased 7% on a year-over-year basis.
Revenues in the International division amounted to $339.3 million, up 17% and 28% year over year on a reported basis and a local currency basis, respectively. The metric missed our estimate of $347.7 million.
Latin America&#39;s revenues of $97.3 million surged 71% from the year-ago quarter on a reported basis and more than 100% on a local currency basis. Revenues from Europe amounted to $88.2 million, up 12% year over year on a reported and local currency basis. Canada&#39;s revenues of $69.2 million increased 4% year over year on a reported basis and 6% on a local currency basis. Revenues from Asia Pacific were $84.6 million, declining 4% from the year-ago quarter on a reported basis and 2% on a local currency basis.
<h3>Operating Results</h3>
Adjusted EBITDA in the second quarter of 2024 amounted to $457.7 million, reflecting a 6.1% increase from the year-ago quarter. The adjusted EBITDA margin was 32%, which declined 70 basis points from the year-ago quarter.
Workforce Solutions&#39; adjusted EBITDA margin was 52.8% compared with 51.5% a year ago. Adjusted EBITDA margin for the USIS division was 33.2% compared with 36% in the second quarter of 2023. The adjusted EBITDA margin for the international segment was 25.6% in comparison with 24.2% in the year-ago quarter.
<h3>Balance Sheet &amp; Cash Flow</h3>
EFX exited the second quarter with cash and cash equivalents of $181.9 million, compared with $201 million at the end of the first quarter of 2024. The company has a long-term debt of $4.7 billion, flat with the preceding quarter.
Cash generated from operating activities amounted to $267.5 million, whereas capital expenditure totaled $136.7 million. The company distributed $48.2 million as dividends in the quarter.
<h3>Q3 and 2024 Outlook</h3>
For the third quarter of 2024, EFX raised its revenue guidance to $1.43-$1.45 billion compared with $1.41-$1.43 billion mentioned previously. It raised the guidance for adjusted earnings per share to $1.75-$1.85 compared with $1.65-$1.75 previously.
For 2024, Equifax raised revenue guidance to $5.69-$5.75 billion compared with $5.67-$5.77 billion previously. The company reduced the adjusted EPS guidance to $7.22-$7.47 compared with $7.2-$7.5 previously.
<h2>How Have Estimates Been Moving Since Then?</h2>
It turns out, estimates revision have trended downward during the past month.
The consensus estimate has shifted -9.82% due to these changes.
<h2>VGM Scores</h2>
Currently, Equifax has an average Growth Score of C, though it is lagging a bit on the Momentum Score front with a D. Following the exact same course, the stock was allocated a grade of D on the value side, putting it in the bottom 40% for this investment strategy.
Overall, the stock has an aggregate VGM Score of D. If you aren&#39;t focused on one strategy, this score is the one you should be interested in.
<h2>Outlook</h2>
Estimates have been broadly trending downward for the stock, and the magnitude of these revisions indicates a downward shift. Notably, Equifax has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.
<a href="https://www.zacks.com/stock/news/2323215/why-is-equifax-efx-up-11-1-since-last-earnings-report?cid=CS-BENZ-FT-realtime_blog-2323215">To read this article on Zacks.com click here.</a>

Earnings

Earnings Beats

Large Cap

Guidance

Dividends

Why Is Equifax Up 11.1% Since Last Earnings Report?

Equifax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>) has outperformed the market over the past 10 years by 3.27% on an annualized basis producing an average annual return of 14.04%. Currently, Equifax has a market capitalization of $36.12 billion. 
Buying $100 In EFX: If an investor had bought $100 of EFX stock 10 years ago, it would be worth $371.56 today based on a price of $291.94 for EFX at the time of writing.
<h3>Equifax's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1723831430_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much You Would Have Made Owning Equifax Stock In The Last 10 Years

Wells Fargo analyst Jason Haas initiates coverage on Equifax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>) with a Overweight rating and announces Price Target of $340.

Wells Fargo Initiates Coverage On Equifax with Overweight Rating, Announces Price Target of $340

Equifax: A Potential Beneficiary Of Interest Rate Cut

50 stocks to invest during the bull steepening – Part 1

Software companies are the key players in the future of business and technology, thus creating a robust environment. Given this backdrop, it could be wise to invest in software stocks that Wall Street seems to love: Intuit (INTU), Workday (WDAY), and Salesforce (CRM). Continue reading… In today's digital world, software companies have become an essential part of the economy, offering both growth and stability in the market. These companies are fueled by generative AI integration in their systems, which makes them more efficient and faster.
These new and evolved advancements are creating an opportunity for investors to invest in software-providing stocks such as Intuit Inc. (<a href="https://stocknews.com/stock/INTU/">INTU</a>), Salesforce, Inc. (<a href="https://stocknews.com/stock/CRM/">CRM</a>), and Workday, Inc. (<a href="https://stocknews.com/stock/WDAY/">WDAY</a>), which are currently finding favors on Wall Street.
Software companies are seeing significant expansion opportunities with the rising demand for cloud computing, AI, cybersecurity, and remote collaboration tools. According to a <a href="https://www2.deloitte.com/us/en/pages/about-deloitte/articles/sustainable-competitive-industry-advantage.html">Deloitte report</a>, nearly 80% of surveyed business leaders expect generative AI to drive substantial transformation within their organizations in the next three years.
Furthermore, the global market software revenue is projected to be <a href="https://www.grandviewresearch.com/industry-analysis/software-market-report#:~:text=USD%201%2C397.31%20billion">$1.39 trillion by 2030</a>, exhibiting a CAGR of 11.5%. This data underscores the strong demand for software solutions across various sectors.
Considering these conducive trends, let's examine the <a href="https://stocknews.com/category/software-application/">Software - Application</a> industry stocks in detail, beginning with the third choice:
Stock #3: Intuit Inc. (<a href="https://stocknews.com/stock/INTU/">INTU</a>)
INTU is a financial technology platform that helps consumers and small businesses prosper by delivering financial management, compliance, and marketing products and services. It operates through four segments: Small Business &amp; Self-Employed; Consumer; Credit Karma; and ProTax. 
On September 4, INTU announced major enhancements to its proprietary Generative AI Operating System (GenOS) that's accelerating development velocity at scale across the company's products and services.
The GenOS includes GenOS AI Workbench, which simplifies and streamlines end-to-end app development and enhancements to GenStudio, GenRuntime, and GenUX components.
On June 20, INTU and the Los Angeles Urban League announced the agreement to extend their partnership with the IDEAS (Invest, Develop, Empower, Accelerate, and Scale) Program. This program will now expand to a total of 100 small business owners, helping them grow and save time and money.
INTU's total net revenue for the fourth quarter (ended July 31, 2024) increased 17.4% year-over-year to $3.18 billion. Its non-GAAP <a href="https://www.investopedia.com/terms/o/operatingincome.asp">operating income</a> grew 16.4% from the prior year's quarter to $730 million. The company's non-GAAP net income for the quarter amounted to $730 million or $1.99 per share, representing an increase of 20.6% from the same period last year.
As per the forward-looking guidance for the fiscal year 2025, INTU forecasts revenue to be between $18.16 billion and $18.35 billion. The company also expects non-GAAP EPS between $19.16 and $19.36 and non-GAAP operating income to range from $7.24 billion to $7.14 billion.
The consensus revenue estimate of $3.88 billion for the fiscal second quarter (ending January 2025) represents a 14.7% increase year-over-year. The consensus EPS estimate of $3.25 for the same quarter indicates a 23.6% improvement year-over-year. The company has an impressive earnings surprise history; it surpassed the consensus EPS estimates in each of the trailing four quarters.
Over the past year, the stock has surged 13.9%, closing the last trading session at $626.99.
Of 22 analysts that rated INTU, 19 rated it Buy, while three rated it Hold. The 12-month median price target of $741.42 indicates <a href="https://www.tipranks.com/stocks/intu/forecast">an 18.3% upside potential</a> from the last closing price. The price targets range from a low of $600 to a high of $795.
INTU's <a href="https://stocknews.com/powr-ratings/">POWR Ratings</a> reflect this robust outlook. The stock has an overall rating of B, which equates to Buy in our proprietary rating system. The POWR Ratings are calculated by considering 118 different factors, with each factor weighted to an optimal degree.
INTU has a B grade for Growth, Sentiment, and Quality. It is ranked #33 out of 125 stocks in the <a href="https://stocknews.com/category/software-application/">Software - Application</a> industry. <a href="https://stocknews.com/stock/INTU/">Click here</a> to see the additional ratings for INTU (Value, Momentum, and Stability).
Stock #2: Workday, Inc. (<a href="https://stocknews.com/stock/WDAY/">WDAY</a>)
WDAY is a global provider of enterprise cloud applications for finance and human resources. It helps customers plan, execute, analyze, and extend to its varied applications to manage their business and operations.
On August 22, WDAY and Equifax Inc. (<a href="https://stocknews.com/stock/EFX/">EFX</a>), a global data analytics and technology company, announced a strategic partnership to help make employment and income verifications for WDAY customers easier and faster with more efficiency and reduced costs.
In the same month, WDAY announced the global release of Workday Payroll powered by Strada. This new AI-powered global HR and payroll solution gives organizations a unified view of their finance, anticipates trends, and customizes payroll services within the organization.
For the second quarter of 2025, which ended on July 31, WDAY's total revenues increased 16.7% year-over-year to $2.09 billion, and its non-GAAP operating income stood at $518 million, indicating a 23% growth from the prior-year quarter period.
Its net income rose 67.1% from the year-ago value to $132 million, while its non-GAAP net income per share stood at $1.75, up 22.4% year-over-year.  Also, the company's free cash flow grew 43.3% from the year-ago value to $516 million.
The company has updated its fiscal year 2025 guidance. It now expects its subscription revenue to range between $7.700 billion and $7.7325 billion, representing a growth of approximately 17%. Additionally, WDAY expects its non-GAAP operating margin to be 25.25%.
Analysts expect WDAY's revenue for the third quarter ending October 31, 2024, to increase 14.1% year-over-year to $2.13 billion, while its EPS for the same period is expected to increase 14.2% from the prior-year quarter to $1.75. The company surpassed consensus revenue and EPS estimates in each of the trailing four quarters, which is impressive.
WDAY shares have surged 19.6% over the past month and 17.6% over the past three months to close the last trading session at $253.52.
Based on 31 Wall Street analysts offering 12-month price targets for WDAY in the last three months, <a href="https://www.tipranks.com/stocks/wday/forecast">the average target price is $287.73</a>, indicating a 13.5% change from the last price, with a high forecast of $352 and a low forecast of $240.
WDAY's bright prospects are reflected in its POWR Ratings. The stock has an overall rating of B, which translates to a Buy in our proprietary rating system.
It also has an A grade for Growth and a B for Sentiment and Stability. Within the same industry, it is ranked #28 out of 125 stocks. <a href="https://stocknews.com/stock/WDAY/">Click here</a> to see WDAY's ratings for Value, Momentum, and Stability.
Stock #1: Salesforce, Inc. (<a href="https://stocknews.com/stock/CRM/">CRM</a>)
CRM provides Customer Relationship Management (CRM) technology that brings companies and customers together worldwide. It supports third-party development and offers global sales, service, and subscription services, enabling data storage, lead tracking, and issue resolution.
On September 5, CRM announced its acquisition of Own Company, a leading provider of data protection and data management solutions, for $1.90 billion in cash. This acquisition is set to enhance CRM's ability to offer customers robust data protection and management solutions.
On July 24, the company announced a strategic partnership with WDAY to create an AI-powered employee service agent to boost productivity, lower costs, and improve the employee experience. The partnership will also deepen WDAY's integration with Slack for seamless collaboration.
In the fiscal 2025 second quarter that ended on July 31, 2024, CRM's total revenue increased 8.4% year-over-year to $9.33 billion. The company reported non-GAAP income from operations of $3.14 billion, indicating a 15.5% growth from the prior year quarter with a non-GAAP operating margin of 33.7% (up 210 bps year-over-year). Its free cash flow increased 20.2% year-over-year to $755 million.
CRM's non-GAAP net income came in at $2.49 million, up 19.1% year-over-year, while its non-GAAP net income per share grew 20.8% from the year-ago value to $2.56.
For the fiscal year 2025, the company's non-GAAP operating margin is projected to be 32.8%, with EPS anticipated to fall between $6.05 and $6.13. On a consolidated adjusted basis, its non-GAAP EPS is expected to range from $10.03 to $10.11.
Street expects CRM's revenue for the fiscal fourth quarter (ending October 2024) to increase 7.2% year-over-year to $9.35 billion. Its EPS for the same period is expected to register a 16% growth from the prior year, settling at $2.45. In addition, it surpassed the consensus revenue and EPS estimates in each of the trailing four quarters, which is promising.
Shares of CRM have gained 9.3% over the past year to close the last trading session at $245.76.
Based on 38 Wall Street analysts offering 12-month price targets for CRM in the last three months, <a href="https://www.tipranks.com/stocks/crm/forecast">the average target price is $307.38</a>, indicating a 25.1% change from the last price, with a high forecast of $352.00 and a low forecast of $236.00.
It's no surprise that CRM has an overall rating of B, equating to a Buy in our POWR Ratings system. It has a B grade for Sentiment and Quality. Out of 125 stocks in the Software - Application industry, CRM is ranked #14.
Beyond what is stated above, we've also rated CRM for Growth, Value, Momentum, and Stability. Get all CRM ratings <a href="https://stocknews.com/stock/CRM/">here</a>.
What To Do Next?
Discover 10 widely held stocks that our proprietary model shows have tremendous downside potential. Please make sure none of these "death trap" stocks are lurking in your portfolio:
<a href="https://report.stocknews.com/free-report/10-stocks-to-sell/?formplacement=artbotad_10sell">10 Stocks to SELL NOW! &gt;</a>

<hr />
CRM shares were trading at $245.81 per share on Tuesday afternoon, up $0.05 (+0.02%). Year-to-date, CRM has declined -6.32%, versus a 16.08% rise in the benchmark S&amp;P 500 index during the same period.
<hr><div style="clear:both;"></div> <h2>About the Author: Anushka Dutta</h2> <img src='https:/wp-content/uploads/2021/08/Anushka-Dutta_Headshot_3.jpg' style="float:left; padding:5px;width:125px;">Anushka is an analyst whose interest in understanding the impact of broader economic changes on financial markets motivated her to pursue a career in investment research.<a href="https://stocknews.com/authors/?author=anushka-dutta">More...</a>The post <a href=https://stocknews.com/news/crm-intu-wday-efx-3-software-stocks-that-wall-street-loves-right-now/>3 Software Stocks That Wall Street Loves Right Now</a> appeared first on <a href=https://stocknews.com/>StockNews.com</a>

3 Software Stocks That Wall Street Loves Right Now

Morgan Stanley analyst Toni Kaplan maintained a Hold rating on Equifax (EFX – Research Report) today and set a price target of $271.00. The company...

Equifax (EFX) Receives a Hold from Morgan Stanley

In a report released today, Manav Patnaik from Barclays maintained a Buy rating on Equifax (EFX – Research Report), with a price target of $380.00....

Equifax (EFX) Gets a Buy from Barclays

Lower interest rates may benefit exchange operators, information analytics companies, Oppenheimer says

Wells Fargo analyst Jason Haas CFA maintained a Buy rating on Equifax (EFX – Research Report) today and set a price target of $375.00. The company'...

Wells Fargo Keeps Their Buy Rating on Equifax (EFX)

Jefferies analyst Surinder Thind maintained a Buy rating on Equifax (EFX – Research Report) today and set a price target of $340.00. The company's ...

Jefferies Sticks to Its Buy Rating for Equifax (EFX)

RBC Capital analyst Ashish Sabadra maintained a Hold rating on Equifax (EFX – Research Report) on October 8 and set a price target of $300.00. The ...

Equifax (EFX) Receives a Hold from RBC Capital

Stifel Nicolaus analyst Shlomo Rosenbaum maintained a Buy rating on Equifax (EFX – Research Report) today and set a price target of $305.00. The co...

Comments

Equifax

Vendite allo scoperto

Equifax (NYSE:EFX) Azioni, Report sulle vendite allo scoperto

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO